Aerie Pharma (AERI) PT Lowered to $24 at Needham & Company

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. INTC
2. AMZN
3. COIN
4. RDDT
5. PINS
6. FSLR
7. SYK
8. DASH
9. ALNY
10. SBUX

Go back to Aerie Pharma (AERI) PT Lowered to $24 at Needham & Company

Aerie Pharma (AERI) Misses Q2 EPS by 3c

August 4, 2021 5:08 PM EDT

Aerie Pharma (NASDAQ: AERI) reported Q2 EPS of ($0.67), $0.03 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $27.2 million versus the consensus estimate of $26.28 million.

Our second quarter 2021 results reflect nearly 51 percent growth in net revenues and 31 percent growth in bottle volumes for our U.S. glaucoma franchise compared to the second quarter of 2020. Our net revenue per bottle remained stable at $89 in the second quarter of 2021, with a year over year increase of $11 per bottle, primarily... More